Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study-Reference-Cited by-同舟云学术

Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study

Published:2020-09-29 Issue:12 Volume:43 Page:2999-3006
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:Dia Care

Author:

Solerte Sebastiano Bruno,D’Addio Francesca,Trevisan Roberto,Lovati Elisabetta,Rossi Antonio,Pastore Ida,Dell’Acqua Marco,Ippolito Elio,Scaranna Cristiana,Bellante Rosalia,Galliani Silvia,Dodesini Alessandro Roberto,Lepore Giuseppe,Geni Francesca,Fiorina Roberta Maria,Catena Emanuele,Corsico Angelo,Colombo Riccardo,Mirani Marco,De Riva Carlo,Oleandri Salvatore Endrio,Abdi Reza^ORCID,Bonventre Joseph V.,Rusconi Stefano,Folli Franco^ORCID,Di Sabatino Antonio,Zuccotti Gianvincenzo,Galli Massimo,Fiorina Paolo^ORCID

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference47 articles.

1. Practical recommendations for the management of diabetes in patients with COVID-19;Bornstein;Lancet Diabetes Endocrinol,2020

2. Clinical Characteristics of Coronavirus Disease 2019 in China

3. Aging, Male Sex, Obesity, and Metabolic Inflammation Create the Perfect Storm for COVID-19

4. COVID-19 and Italy: what next;Remuzzi;Lancet,2020

5. A pneumonia outbreak associated with a new coronavirus of probable bat origin

Cited by 211 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential use of plant-based therapeutics for the management of SARS-COV2 infection in diabetes mellitus – a review;Journal of Herbal Medicine;2024-09

2. Vaccinome Landscape in Nearly 620 000 Patients With Diabetes;The Journal of Clinical Endocrinology & Metabolism;2024-07-23

3. Repurposing DPP-4 Inhibitors as a Novel Intervention in COVID-19: In Silico Analysis for SARS-CoV-2 Spike Glycoprotein Inhibition;Proceedings of the National Academy of Sciences, India Section B: Biological Sciences;2024-05-30

4. Identification of DPP‐IV inhibitory peptides derived from buffalo colostrum: Mining through bioinformatics, in silico and in vitro approaches;Journal of Molecular Recognition;2024-05-27

5. Frequency of Mortality and Adverse Outcomes of COVID-19 in Hospitalized Type 2 Diabetics with a History of Sitagliptin or Metformin Use;Jundishapur Journal of Chronic Disease Care;2024-05-07